SCHEMBL5448787

SCHEMBL5448787

CN1C(=O)CC(=O)N(CCCCc2ccccc2)C1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.64
KMT2A Q03164 3/20 0.64
MEN1 O00255 2/20 0.64
USP2 O75604 2/20 0.64
L3MBTL1 Q9Y468 2/20 0.64
GAA P10253 2/20 0.64
HSD17B10 Q99714 2/20 0.64
HTT P42858 1/20 0.64
BLM P54132 2/20 0.61
KDM4E B2RXH2 1/20 0.61
POLB P06746 1/20 0.61
RECQL P46063 1/20 0.61
FAAH O00519 1/20 0.55
MGLL Q99685 1/20 0.55
GSK3A P49840 2/20 0.54
GSK3B P49841 2/20 0.54
TDP1 Q9NUW8 1/20 0.53
SIGMAR1 Q99720 4/20 0.46
ALDH1A1 P00352 3/20 0.44
APAF1 O14727 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5450541 0.95 MAPT (0.66) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL10158770 0.91 MAPT (0.77) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL11789844 0.89 KMT2A (0.81) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL5447108 0.88 MAPT (0.69) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL5442584 0.87 MAPT (0.67) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL10158775 0.85 MAPT (0.80) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL5444965 0.83 MAPT (0.71) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL5440814 0.82 MAPT (0.69) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL5450757 0.81 KMT2A (0.69) MAPTKMT2AMEN1USP2L3MBTL1
SCHEMBL10159078 0.80 MAPT (0.61) MAPTKMT2AMEN1USP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US claimed
US-20050262647-A1 Agent for dyeing fibers containing keratin HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2005-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative KRT18, NDUFB5, NDUFB7 MAPT 685/4885KMT2A 927/4885MEN1 2976/4885
US-20050262647-A1 Agent for dyeing fibers containing keratin KRT18, CKAP4, KRTCAP2 MAPT 646/4885KMT2A 910/4885MEN1 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.